JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
124 hedge funds and large institutions have $343M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 14 closing their positions.
Holders
124
Holders Change
+9
Holders Change %
+7.83%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
37
Reduced
36
Closed
14
Calls
$396K
Puts
$1K
Net Calls
+$395K
Net Calls Change
+$5K
